Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Expert Review of Anticancer Therapy|November 17, 2015
Recent advances in squamous non-small cell lung cancer: evidence beyond predictive biomarkersCarlo Genova, Erika Rijavec, Francesco GrossiInternational Journal of Molecular Sciences|May 5, 2021
Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid TumorsAlice Indini, Erika Rijavec, Francesco GrossiCurrent Opinion in Oncology|January 8, 2016
Hematopoietic growth factors in lung cancerCarlo Genova, Erika Rijavec, Francesco GrossiCancers|April 30, 2021
Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive ReviewAlice Indini, Erika Rijavec, Francesco GrossiJournal of Thoracic Disease|July 10, 2020
Novel treatment strategies for early-stage lung cancer: the oncologist's perspectiveAlice Indini, Erika Rijavec, Claudia Bareggi, et al.Oncotargets and Therapy|November 8, 2014
Ramucirumab: preclinical research and clinical developmentGiuseppe Aprile, Erika Rijavec, Caterina Fontanella, et al.Molecular and Clinical Oncology|March 7, 2022
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review)Erika Rijavec, Federica Biello, Giulia Barletta, et al.Pharmaceutics|June 2, 2021
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS InhibitorsAlice Indini, Erika Rijavec, Michele Ghidini, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemicAlice Indini, Erika Rijavec, Michele Ghidini, et al.Clinical Pharmacology : Advances and Applications|January 27, 2022
Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on BrigatinibErika Rijavec, Federica Biello, Alice Indini, et al.Pageof 10